Latest News in the pharma Industry

Research & Development

Rigel and BMS Announce R&D Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications

Rigel and BMS Announce R&D Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications

26 Feb 2015

Read more 
Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro

Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro

25 Feb 2015

Read more 
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status

New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status

23 Feb 2015

Read more 
NIH-Funded Scientists Create Potential Long-Acting HIV Therapeutic

NIH-Funded Scientists Create Potential Long-Acting HIV Therapeutic

20 Feb 2015

Read more 
Lilly Provides Update on Evacetrapib Phase III Trial

Lilly Provides Update on Evacetrapib Phase III Trial

20 Feb 2015

Read more 
FDA Grants Genentech's Cobimetinib Priority Review for Use in Combination with Zelboraf in Advanced Melanoma

FDA Grants Genentech's Cobimetinib Priority Review for Use in Combination with Zelboraf in Advanced Melanoma

19 Feb 2015

Read more 
Sanofi and Lead Pharma to Develop Treatments for Autoimmune Diseases

Sanofi and Lead Pharma to Develop Treatments for Autoimmune Diseases

19 Feb 2015

Read more 
Pioneering Separations Company Quad Technologies Set To Revolutionize Cell Isolation Following Successful Investment

Pioneering Separations Company Quad Technologies Set To Revolutionize Cell Isolation Following Successful Investment

18 Feb 2015

Read more 
NIH Researchers Reveal Link Between Powerful Gene Regulatory Elements and Autoimmune Diseases

NIH Researchers Reveal Link Between Powerful Gene Regulatory Elements and Autoimmune Diseases

17 Feb 2015

Read more 
Novartis' Heart Failure Medicine LCZ696 Granted FDA Priority Review

Novartis' Heart Failure Medicine LCZ696 Granted FDA Priority Review

16 Feb 2015

Read more 
AbbVie Submits NDA in Japan for its Investigational, All-Oral, Treatment for Chronic Hepatitis C

AbbVie Submits NDA in Japan for its Investigational, All-Oral, Treatment for Chronic Hepatitis C

13 Feb 2015

Read more 
New Source of Cells for Modeling Malaria

New Source of Cells for Modeling Malaria

6 Feb 2015

Read more